Astellas Pharma Inc. is a global pharmaceutical company with a simple vision – to produce exceptional medicines that change tomorrow for patients in need. Headquartered in Tokyo, Astellas was founded in 2005 through the merger of Yamanouchi and Fujisawa, marrying nearly two centuries of collective experience in producing pharmaceutical drugs. We combine the deep expertise brought by this long heritage with the forward-thinking outlook of a young company. At the heart of that outlook is the patient.

With our ethos of CHANGING TOMORROWTM, Astellas is committed to exploring therapeutic areas in which there is a vital need for treatments that improve and lengthen patients’ lives. Based on this, we have defined six therapeutic areas as our priorities for improving the future of patients .

                o   Transplantation

                o   Urology

                o   Anti-Infectives

                o   Pain Management


Now, Astellas employs more than 17,500 people globally and is a world leader in the development of innovative new medicines.